Practice parameters, as developed by the Joint Task Force on Practice Parameters, are documents that establish boundaries for appropriate patient care. They acknowledge the range or variations that currently take place in the allergy community regarding management of allergic conditions and use of procedures to diagnose and treat these conditions. They attempt to promote consistency in practice while allowing for variable approaches based on individual patient differences using evidence from the medical literature to achieve good clinical practice.
To view the practice parameters, please visit the Food Allergy Practice Parameters page.
Below is a list of selected resources for this topic area that the College has discovered and believes are relevant to our members. These resources are curated by the College but are not directly developed or administered by the College. For the learning activities developed by the college for this topic, please visit the Course Catalog.
|Reading (Article, PDF, etc.)||JACI||2015||0.00||$0.00|
|Breast-feeding is protective against respiratory infections in early life. Given the co-evolutionary adaptations of humans and cattle, bovine milk might exert similar anti- infective effects in human infants.|
|Reading (Article, PDF, etc.)||WAO||2012||0.00||$0.00|
|The estimated prevalence of cow's milk allergy (CMA) varies between 0.25% and 4.9%, being higher in children than adults.1 The prevalence is higher in referral populations, depending on the nature of the basic condition. For instance, in a consecutive series with moderate atopic eczema referred to a University-affiliated dermatology department, SPT showed 16% of infants with IgE against CMP.2 In a group of infants and children with AD and no other allergic manifestations, 37% had a diagnosis of CMA.3 Cow's milk allergy can develop in exclusively or partially breast-fed infants, when cow's milk protein is introduced into the feeding regime. The incidence of CMA is lower in exclusively breast-fed infants compared to formula-fed or mixed-fed infants, and clinical reactions in the breast-fed group are mostly mild to moderate. This might be related to lower levels of CMP in breast milk compared to cow's milk. Immunomodulators in breast milk and differences in gut flora between breast-fed and formula-fed infants may also play a role.|
|Reading (Article, PDF, etc.)||AAAAI||2013||20.00||$0.00|
|This module is based on the NIAID Guideline for the Diagnosis and Management of Food Allergy in the United States. Allergist/immunologists can analyze their diagnosis and management of food allergy patients and implement tools to enhance patient care and education.|
|Podcast (MP3, etc.)||World Allergy Organization (WAO)||2009||0.00||$0.00||MP3 Format, 4.3|
|Sami Bahna, MD, DrPH LSU Medical School Shreveport, Louisiana (USA) Conducted by: Bob Q. Lanier, MD|
|Podcast (MP3, etc.)||World Allergy Organization (WAO)||2008||0.00||$0.00||MP3 Format, 11.3 MB|
|Scott Sicherer, MD University of Chicago Chicago, Illinois (USA) Conducted by: Paul Potter, MD|
|E-Learning||World Allergy Organization (WAO)||2008||2.00||$0.00||Renewal expired January 18, 2013|
|Upon completion of this activity, participants will be able to: 1) Analyze a complex case history on Food Allergy with reference to current Web-based medical information; 2) Describe the natural history of allergic symptoms related to IgE-mediated Food Allergy commencing in childhood; 3) Select and interpret correctly appropriate diagnostic tests for suspected Food Allergy; Develop a management plan including dietary advice for a patient with IgE-mediated Food Allergy; 5) Plan the most appropriate treatment for a child at risk from anaphylaxis; 6) Recognize the importance of educating parents and the wider community in the management of children with Food Allergy and Anaphylaxis; Interpret the significance of cross-reactivity between peanut and tree nuts in Food Allergy; and 8) Summarize the practical problems encountered by Food Allergic patients wishing to travel by air.|
|Webinar||ACAAI House of Delegates||2016||0.00||$0.00|
|ACAAI’s House of Delegates proudly presented James R. Baker, Jr., MD, chief executive officer and chief medical officer of the Food Allergy Research and Education (FARE) organization, who provided details about how the decisions of the Food and Drug Administration's Allergenic Products Advisory Committee meeting on Jan. 21 will affect your allergy practice - in a live webinar Tuesday, March 1, 2016. The webinar was recorded and is now available.|